Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, B-Cell » Lymphoma, B-Cell, Marginal Zone
Diseases [C] » Hemic and Lymphatic Diseases [C15] » Lymphatic Diseases » Lymphoproliferative Disorders » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, B-Cell » Lymphoma, B-Cell, Marginal Zone
Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Lymphoproliferative Disorders » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, B-Cell » Lymphoma, B-Cell, Marginal Zone
Description
Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder. MeSH
Hierarchy View
Approved Indicated Drugs (1)
Phase 3 Indicated Drugs (17)
Other Experimental Indicated Drugs (12)
Organization Involved with Phase 3 Indications (18)
Organization Involved with Phase 2 Indications (107)
Academic and Community Cancer Research United
Arbeitsgemeinschaft medikamentoese Tumortherapie
Badalona Hospital Germans Trias i Pujol
Beijing InnoCare Pharma Tech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd.
Case Western Reserve University
Chinese Academy of Medical Sciences
City of Hope National Medical Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Hospital Universitario Central de Asturias
Nanjing Sanhome Pharmaceutical, Co., Ltd.
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
North Central Cancer Treatment Group
Ospedale degli Infermi di Biella
Ospedale S. Giovanni Bellinzona
State University of New York, Buffalo
Universidad Autonoma de Barcelona
Universidad Autonoma de Madrid
Universidad Complutense de Madrid
University of Colorado, Denver
University of Las Palmas de Gran Canaria
University of Medicine and Dentistry of New Jersey
University of North Carolina at Chapel Hill
University of Roma La Sapienza
University of Texas at Houston
Organization Involved with Phase 1 Indications (26)
Organization Involved with Other Experimental Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
